Increasing PTS using multimodal data

Advancing IO therapeutics: The convergence of novel biomarkers and combination strategies

Explore the latest in immuno-oncology (IO), where emerging therapies are reshaping the landscape of cancer treatment. This webinar will focus on the role of novel biomarkers and combination treatment strategies in understanding and enhancing the immune system's response to cancer. Discover the significant developments that are helping to shape clinical trials and improving patient outcomes in IO and hear perspectives from industry experts on the potential of emerging therapies.

Watch replay

The future of immuno-oncology research: Challenges, innovations, and the role of data-driven solutions

This white paper offers an in-depth look at immuno-oncology (IO) research, emphasizing how data-driven research propels therapy development and enhances treatment efficacy. Download for a comprehensive analysis of the IO landscape, its projected market growth, and insights regarding pharmaceutical companies' strategic approaches to optimize therapeutic outcomes.

Read more

Maximizing precision in pathology: the Critical Path approach

Enhancing tissue utilization, reducing turnaround time, and optimizing testing pathways with AI-driven insights.

Read more